Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Murchison South Increases to 67koz Gold Across Two Pits May 13, 2025 Rae Copper Project delivers further high-grade mineralisation with 63m @ 2.23% Copper May 13, 2025 John Feneck: Key Gold, Silver Price Levels, 10+ Mining Stocks I’m Watching May 13, 2025